Medindia
Medindia LOGIN REGISTER
Advertisement

Dynacure Receives Orphan Drug Designation from the US FDA for DYN101, an Antisense Medicine to Treat Rare Disease 'Centronuclear Myopathies'

Thursday, August 8, 2019 General News
Advertisement
Company expects to initiate Phase 1 / 2 study 'Unite-CNM' in 2H2019

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close